Volume 28, Issue 2 - Generics and biosimilars

Statistical principles in biosimilar development

Authors: Alison Balfour, Susanne Schmitt

Abstract

Download the full article

References

1. European Medicines Agency. Guideline on the Investigation of Bioequivalence. 2010 Jan 29 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa.eu/en/ investigation-bioequivalence.
2. US Food and Drug Administration. Statistical Approaches to Establishing Bioequivalence. 2001 Jan [cited 2019 Mar 27]. Available from: Available from: https://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory Information/Guidances/UCM070244.pdf.
3. European Medicines Agency. Similar Biological Medicinal Products Containing Biotechnology-derived Proteins as Active Substance: Non-clinical and Clinical Issues. 2015 Jan 09 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa.eu/en/ similar-biological-medicinal-productscontaining- biotechnology-derivedproteins- active-substance-non.
4. European Medicines Agency. Guideline on similar biological medicinal products. 2014 Oct 23 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa.eu/en/ documents/scientific-guideline/guidelinesimilar- biological-medicinal-productsrev1_ en.pdf.
5. US Food and Drug Administration. Questions and Answers on Biosimilar Development and the BPCI Act. 2018 Dec [cited 2019 Mar 27]. Available from: Available from: https://www.fda.gov/downloads/drugs/ guidances/ucm444661.pdf.
6. European Medicines Agency. Points to Consider on Multiplicity Issues in Clinical Trials. 2002 Sep 19 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa. eu/en/documents/scientific-guideline/ points-consider-multiplicity-issues-clinicaltrials_ en.pdf.
7. European Medicines Agency. Guideline on the Choice of the Non-Inferiority Margin. 2005 Jul 27 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa.eu/ en/choice-non-inferiority-margin.
8. US Food and Drug Administration. Non- Inferiority Clinical Trials to Establish Effectiveness. 2016 Nov [cited 2019 Mar 27]. Available from: Available from: https://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory Information/Guidances/UCM202140.pdf.
9. European Medicines Agency. Guideline on Similar Biological Medicinal Products Containing Monoclonal Antibodies – Non-clinical and Clinical Issues. 2012 Jun 15 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa. eu/en/similar-biological-medicinalproducts- containing-monoclonalantibodies- non-clinical-clinical-issues.
10. European Medicines Agency. Guideline on Missing Data in Confirmatory Clinical Trials. 2010 Sep 20 [cited 2019 Mar 27]. Available from: Available from: https://www.ema.europa.eu/en/missingdata- confirmatory-clinical-trials.